News|Articles|January 28, 2026
Lab to Launch Faster
Author(s)Fujifilm
Case study showcasing accelerated PPQ for an E. coli–expressed orphan therapy, achieving three PPQ batches in 18 months through high-compliance manufacturing.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5